Emergent BioSolutions Inc. (EBS)
NYSE
Closed
Oct 8, 2026
Day's Range
6.7952 wk Range
4.36Profile - EBS - Emergent BioSolutions Inc.
Profile
Mic Code
XNYS
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
900
Emergent BioSolutions Inc. is a life sciences company focused on preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats. Its current business centers on medical countermeasures and specialty products, including public health protection tools used by government agencies, healthcare providers, and other institutional customers. The company’s portfolio includes commercial products, medical countermeasure products, and services, with an emphasis on areas such as opioid overdose reversal, smallpox and anthrax preparedness, and contract development and manufacturing support. Emergent BioSolutions plays a specialized role in the healthcare and biodefense markets by supplying products and services designed to support emergency readiness and public health response across the United States and international markets.
Profile Details
Type
Common Stock
Address
300 Professional Drive
City
Gaithersburg
State
MD
Zip
20879
Country
United States
Phone
240 631 3200
Key Executives - EBS - Emergent BioSolutions Inc.
Key executives
Cross Listings - EBS - Emergent BioSolutions Inc.
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
